<ѻý>First Interchangeable Humira Biosimilar Approvedѻý> Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<ѻý>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻý> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻý>Statins Not Linked With Rheumatoid Arthritis, Large Study Findsѻý> Risks attenuated after adjustment for lipid levels Sep 22, 2021
<ѻý>Lymphoma in RA: Disease Activity Mattersѻý> Strongest risk factors were baseline disease activity scores and bone erosions Sep 08, 2021
<ѻý>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risksѻý> Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<ѻý>New-Onset IBD and IL-17 Inhibitors: What Is the Risk?ѻý> Underlying inflammatory disease severity should be taken into account Jul 21, 2021
<ѻý>CV Risk in PsA: Do Drugs Matter?ѻý> Study weighs in on heart safety of TNF inhibitors versus other biologics Jul 19, 2021
<ѻý>Effective Treatments for Hand Osteoarthritis: The Search Goes Onѻý> Hydroxychloroquine not effective as disease-modifying drug for erosive hand OA, trial confirmed Jul 08, 2021
<ѻý>Rinvoq Shows Promise in Spine Diseaseѻý> 1-year results in ankylosing spondylitis demonstrate efficacy for JAK inhibitor upadacitinib Jul 02, 2021
<ѻý>Target TNF or IL-12/23 in Psoriatic Arthritis?ѻý> Both TNF inhibitors and ustekinumab were effective in real-world use Jun 30, 2021
<ѻý>New ACR Rheumatoid Arthritis Guideline: Emphasis on Methotrexateѻý> Many RA patients succeed with optimized use of the DMARD before adding another medication Jun 28, 2021
<ѻý>Pain Persists in RA, Even Without Inflammationѻý> At 5 years, one-third of patients with rheumatoid arthritis still had "unacceptable" pain Jun 22, 2021
<ѻý>Osteoarthritis: A Link With Parkinson's?ѻý> Inflammation may contribute to both joint and nerve degeneration Jun 09, 2021
<ѻý>Rituximab a Hazard in RA Patients With COVIDѻý> Poor outcomes were fourfold higher among rituximab users than for those on TNF inhibitors Jun 03, 2021
<ѻý>Plaque Psoriasis Drug Shows Promise for Psoriatic Arthritisѻý> Monoclonal antibody targets the IL-23 p19 subunit May 20, 2021
<ѻý>For Safety, One Biologic a Winner in Psoriasis, Psoriatic Arthritisѻý> Lower hospitalization rates compared with other biologics or small molecule therapies May 19, 2021
<ѻý>Stopping IL-17 Drug for Axial Spondyloarthritis? Expect Spinal Flaresѻý> But low disease activity regained if treatment restarted May 11, 2021
<ѻý>The Death of One Little Girl Helped Millionsѻý> A case more than 35 years ago has spurred discoveries ever since May 07, 2021 podcast
<ѻý>Results Disappoint for Fecal Transplant in Arthritisѻý> But interest persists in targeting the gut-joint axis in psoriatic arthritis May 04, 2021
<ѻý>Pegloticase Safe for Dialysis Patients With Goutѻý> Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
<ѻý>For Enthesitis in Psoriatic Arthritis, Target IL-23ѻý> Targeted agent provides relief for many PsA patients Apr 08, 2021
<ѻý>JAK Inhibitor Promising in Psoriatic Arthritisѻý> Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<ѻý>FDA Panel Unhappy With Novel OA Pain Drugѻý> Latest setback for troubled osteoarthritis biologic Mar 25, 2021
<ѻý>Don't Stop Taltz in Psoriatic Arthritisѻý> Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
<ѻý>JAK Inhibitor a Hit With RA Patientsѻý> Superior to adalimumab on many patient-reported outcomes Feb 26, 2021
<ѻý>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻý> Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<ѻý>PET Scans Reveal Vascular Inflammationѻý> In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
<ѻý>Spinal Benefits Seen With Cosentyx in PsAѻý> First trial to evaluate response of axial symptoms in psoriatic arthritis to biologic treatment Dec 22, 2020
<ѻý>TYK2 Inhibition Promising in Psoriatic Arthritisѻý> Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<ѻý>COVID Complications Common with Rheumatic Diseaseѻý> Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
<ѻý>Rinvoq for RA: Benefits Persist Beyond 1 Yearѻý> Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
<ѻý>Military Burn Pits Linked With RA Seropositivityѻý> Highest risks for anti-CCP antibodies seen for smokers and those with the HLA-DRB1 shared epitope genes Oct 23, 2020
<ѻý>FDA Warns Against NSAIDs in Pregnancy After 20 Weeksѻý> Risk of kidney complications and low amniotic fluids may jeopardize fetus Oct 15, 2020
<ѻý>Upadacitinib, Abatacept Go Head to Head in RAѻý> And the winner is... both, depending on whether efficacy or safety is the main criterion Oct 14, 2020
<ѻý>Depression and Biologic Use in Arthritis: Chicken or Egg?ѻý> Relationship appears to be bi-directional, researchers say Oct 02, 2020
<ѻý>Capsaicin Injection Improves Knee OA Painѻý> Investigational treatment targets capsaicin receptor to inactivate local pain fibers Sep 06, 2020
<ѻý>Joint Effusion Protective in Hand OAѻý> Unlike synovitis, which was linked with both pain and progression Sep 03, 2020
<ѻý>Al Roker's Shoulder Replacementѻý> "Today" co-host and weatherman battles osteoarthritis pain Aug 25, 2020
<ѻý>Baricitinib and Infections: What's the Risk?ѻý> Overall infections increased, but serious infections similar to placebo Aug 17, 2020